Torrent acquires a derma company. Speed jumps ranks in the category.

Torrent Pharmaceuticals (TP) has entered into definitive agreements to acquire 100% stake in Curatio Health Care (I) Private Limited (“Curatio”), a Chennai based dermatology company with a strong focus on cosmetic dermatology.

  • Curatio was founded in 2005 and is backed by Sequoia, Anicut and ChrysCapital.
  • It has a strong presence in the cosmetic dermatology segment with a portfolio of over 50 brands, marketed in India. The portfolio consists of leading brands such as Tedibar, Atogla, Spoo, B4 Nappi, and Permite, which are ranked amongst top 5 brands in their covered market. 95% of it’s revenues comes from dermatology brands
  • Curatio’s turnover track record
    • FY 20 – Rs 175 crore
    • FY 21 – Rs 180 crore
    • FY 22 – Rs 224 crore
    • FY 23 – projected of Rs 275 crore
  • Purchase consideration is Rs. 2,000 crore.
    • Rs. 115 crores for cash and cash equivalents in Curatio
    • Balance Rs 1,885 crore Enterprise Valuations
  • Implied FY 23 valuation  = 7x sales. This is not cheap but then this is not a cheap market either !

Rationale for acquisition

The subject acquisition allows TP to improve it’s position significantly in the dermatology category from 21 pre-acquisition to 10 post-acquisition.

The Company also expects to leverage it’s own resources and better utilise Curatio’s online and offline selling experience to further push forward into the category.

Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x